Researcher
Veerle SOMERS
- Keywords:Biomedical sciences (incl. biochemistry)
- Disciplines:Autoimmunity, General diagnostics, Adaptive immunology, Musculo-skeletal systems, Developmental neuroscience
Affiliations
- Immunology & Infection (Department)
Member
From1 Jan 2020 → Today - Immunology & Infection (Research group)
Member
From1 Jan 2020 → Today - Biomedical Research Institute (Research institute)
Member
From11 Dec 2003 → Today - Faculty of Medicine and Life Sciences (Faculty)
Member
From16 Jan 2003 → Today - Immunology - Biochemistry (Research group)
Member
From11 Dec 2003 → 31 Dec 2019 - Physiology - Biochemistry - Immunology (Department)
Member
From1 Oct 2003 → 31 Dec 2019 - Medical Basic Sciences (Division)
Member
From16 Jan 2003 → 30 Sep 2009
Projects
1 - 10 of 48
- Francqui Chair prof. dr. SwinnenFrom1 Oct 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Novel antibody biomarkers for the prediction of response to first-line therapy in rheumatoid arthritisFrom15 Jan 2023 → 14 Jan 2024Funding: IOF - technology concept exploration
- Spinal cord injury induced autoantibodies as biomarkers for patient stratificationFrom1 Nov 2022 → TodayFunding: FWO Strategic Basic Research Grant
- Anti-UH-RA antibody reactivity for prediction of response to first-line therapy in rheumatoid arthritis: validation in the independent CAP48 cohort.From1 Oct 2022 → 1 Dec 2023Funding: Foundations, funds and other with scientific goal
- Deep immune-phenotyping of multiple sclerosis patients using advanced spectral flow cytometryFrom1 Jan 2022 → 31 Dec 2023Funding: Foundations, funds and other with scientific goal
- The MIF-CD74 system as a driver of pro-inflammatory B cell responses following traumatic spinal cord injury (SCI).From1 Oct 2021 → TodayFunding: BOF - doctoral mandates
- Elucidating the role of double homeobox protein 4 (DUX4) in the pathology of inflammatory arthritisFrom1 Jan 2021 → 31 Dec 2021Funding: Foundations, funds and other with scientific goal
- Understanding how B cell depletion with ocrelizumab affects the immune system in the treatment of MSFrom1 Jan 2021 → 30 Jun 2023Funding: Foundations, funds and other with scientific goal
- Spinal cord injury induced autoantibodies as biomarkers for patient stratificationFrom1 Nov 2020 → 31 Oct 2022Funding: FWO Strategic Basic Research Grant
- Protective versus damaging aspects of the immune reaction in relation to clinical outcome in the Limburg COVID-19 cohortFrom15 Jun 2020 → 14 Jun 2022Funding: BOF - projects
Publications
31 - 40 of 127
- Letter to the Editor concerning the article “Application of red light phototherapy in the treatment of radioactive dermatitis in patients with head and neck cancer(2019)
Authors: Jolien ROBIJNS, S Censabella, S Claes, L Pannekoeke, L Bussé, D Colson, I Kaminski, V Broux, Joy LODEWIJCKX, S Puts, et al.
- Phenotypic and Ig Repertoire Analyses Indicate a Common Origin of IgD-CD27- Double Negative B Cells in Healthy Individuals and Multiple Sclerosis Patients(2019)
Authors: Judith FRAUSSEN, Susanna Marquez, Kazushiro Takata, Lien BECKERS, Gwendoline MONTES DIAZ, Chrysoula Zografou, Bart VAN WIJMEERSCH, Luisa M. Villar, Kevin C. O'Connor, Steven H. Kleinstein, et al.
Pages: 1650 - 1664 - Antigenic Targets of Patient and Maternal Autoantibodies in Autism Spectrum Disorder(2019)
Authors: Rut MAZON CABRERA, Patrick VANDORMAEL, Veerle SOMERS
- Raising to the Challenge: Building a Federated Biobank to Accelerate Translational Research—The University Biobank Limburg(2019)
Authors: Loes LINSEN, Kimberly VANHEES, Evi VANOPPEN, Kim ULENAERS, Suzanne Driessens, Joris PENDERS, Veerle SOMERS, Piet STINISSEN, Jean-Luc RUMMENS
- Prevention of acute radiodermatitis by photobiomodulation: A randomized, placebo-controlled trial in breast cancer patients (TRANSDERMIS trial).(2018)
Authors: Jolien ROBIJNS, Sandrine Censabella, Stefan Claes, Luc Pannekoeke, Lore Bussé, Dora Colson, Iris Kaminski, Paul BULENS, Annelies MAES, Leen Noé, et al.
Pages: 763 - 771 - SCREENING FOR ANTIBODY REACTIVITY IN EARLY AXIAL SPONDYLOARTHRITIS IDENTIFIES NOVEL ANTIGENIC TARGETS(2018)
Authors: Dana QUADEN, Patrick VANDORMAEL, Kristoff CORTEN, Johan VANHOOF, Piet GEUSENS, Veerle SOMERS
Pages: 1215 - 1215 - Dimethyl fumarate treatment in multiple sclerosis: Recent advances in clinical and immunological studies.(2018)
Authors: Raymond Hupperts, Judith FRAUSSEN, Gwendoline MONTES DIAZ, Veerle SOMERS
Pages: 1240 - 1250 - Photobiomodulation prevents acute radiodermatitis: final results of a RCT in bre ast cancer patients(2018)
Authors: Jolien ROBIJNS, S. Censabella, S. Claes, L. Pannekoeke, L. Busse, I. Kaminksi, D. Colson, Annelies MAES, Paul BULENS, L. Noe, et al.
Pages: S49 - S49 - AUTOANTIBODIES TO A NOVEL PEPTIDE UH-RA. 1 ARE ASSOCIATED WITH DISEASE REMISSION IN RHEUMATOID ARTHRITIS(2018)
Authors: Liesbeth DE WINTER, Patrick VANDORMAEL, V. Stouten, H. W. van Steenbergen, Piet GEUSENS, Jan Lenaerts, A. H. M. van der Helm-van Mil, P. Verschueren, Veerle SOMERS
Pages: 1324 - 1325 - Photobiomodulation therapy prevents severe acute radiodermatitis: a randomized, placebo-controlled trial in breast cancer patients with clinical and objective outcome measures(2018)
Authors: Jolien ROBIJNS, S. Censabella, S. Claes, L. Pannekoeke, L. Bussé, D. Colson, I. Kaminksi, Paul BULENS, Annelies MAES, L. Noé, et al.
Pages: S47 - S47
Patents
1 - 9 of 9
- Method and means for diagnosis of spondyloarthritis (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- MEANS AND METHODS FOR THE DETERMINATION OF THE JOINT DESTRUCTION PROGRESSION RATE IN RHEUMATOID ARTHRITIS PATIENTS (Inventor)
- BIOMARKERS FOR MULTIPLE SCLEROSIS (Inventor)
- CITRULLINATION SPECIFIC PHAGE DISPLAY (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- CITRULLINATION SPECIFIC PHAGE DISPLAY (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- BIOMARKERS FOR RHEUMATOID ARTHRITIS (Inventor)
Linked dataset
1 - 1 of 1